Pay in 4 interest-free payments of $6.76 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Side-by-Side Comparison Parameter Receptors Cagrilintide AMY1R/2R/3R + CTR Semaglutide GLP-1R Tirzepatide GLP-1R + GIPR Retatrutide GLP-1R + GIPR + Glucagon-R Parameter Half-life Cagrilintide ~7-8 days Semaglutide ~7 days Tirzepatide ~5 days Retatrutide ~6 days Parameter Dosing frequency Cagrilintide Once weekly Semaglutide Once weekly Tirzepatide Once weekly Retatrutide Once weekly Parameter Max studied dose Cagrilintide 4.5 mg/week (mono) Semaglutide 2.4 mg/week Tirzepatide 15 mg/week Retatrutide 12 mg/week Parameter Peak monotherapy weight loss Cagrilintide 11.8% at 68 wk Semaglutide 14.9-17% at 68 wk Tirzepatide 22.5% at 72 wk Retatrutide ~24% at 48 wk Parameter FDA status (June 2026) Cagrilintide Investigational Semaglutide Approved (2021) Tirzepatide Approved (2023) Retatrutide Investigational Parameter HbA1c reduction (T2D) Cagrilintide ~0.9 pp mono
Its important to consult with our team before getting any treatment during pregnancy or breastfeeding
How Much Bacteriostatic Water to Mix with 3 mg of Semaglutide
Anti-inflammatory Researched as an anti-inflammatory agent in animal-only studies
Selecting a preset automatically fills that value, and you can mix presets with custom entries
Up to 1ml can be injected into this site in neonates, up to 3mls in children and up to 5mls in adults
US$ 26.13
US$ 27.56
US$ 25.88
US$ 29.63
US$ 28.60
US$ 23.74
US$ 21.14
US$ 23.37
US$ 25.02
